Key result
Hypertensive heart disease mortality in China drops ~51% despite projected increases in absolute prevalent cases.
Why the study?
Hypertensive heart disease is a significant public health concern in China, prompting an updated estimate of its burden between 1990 and 2030.
Observational
Answers are grounded in this paper and cite their sources.
Despite decreasing age-standardized mortality rates, the absolute prevalence of hypertensive heart disease in China is projected to increase significantly by 2030, highlighting the need for improved hypertension management and lifestyle interventions.
BACKGROUND: Hypertensive heart disease (HHD) is a significant public health concern in China. We intend to provide an updated estimate of the burden of HHD in China between 1990 and 2030. METHODS: HHD prevalence, mortality, and disability-adjusted life years (DALYs) data were obtained from Global Burden of Disease (GBD) 2019 databases. Temporal trends of HHD from 1990 to 2019 were analyzed using Joinpoint regression models, and projections through 2030 were estimated by Bayesian age-period-cohort model. RESULTS: In 2020, an estimated 334,695 newly prevalent cases and 13,196 deaths due to HHD occurred in China. From 1990 to 2019, age-standardized rate of prevalence (ASPR), mortality (ASMR) and DALYs (ASDR) showed a decreasing trend. The behavior-related risk, diet risk and excessive BMI were the most common reasons of death in HHD. According to our prediction, ASMRs and ASDRs will continue to decrease from 2020 to 2030. However, ASPRs will have a moderate rise. CONCLUSION: HHD continues to pose a significant threat to public health in China. To achieve the Healthy China 2030 objective, a tailored approach involving comprehensive strategies is essential. These strategies should include, but are not limited to, enhancing public awareness about hypertension through educational campaigns, improving access to healthcare services for early diagnosis and treatment, implementing policies to promote healthy lifestyles, such as regular physical activity and a balanced diet, and strengthening the surveillance and monitoring systems to track the prevalence and impact of HHD over time.
No takes yet. Share an insight, caveat, or question.
Lian et al. (2025) conducted an observational in Hypertensive heart disease. The age-standardized mortality rate of hypertensive heart disease in China decreased by 51.2% from 1990 to 2019, though the absolute number of prevalent cases is projected to increase by 2030.
Synapse has enriched 10 related papers. Consider them for comparative context: